# Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis

> **NCT00232115** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 124 (actual)

## Conditions studied

- Perioral Dermatitis

## Interventions

- **DRUG:** Pimecrolimus
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00232115
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** 2006-07
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2008-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00232115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00232115, "Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT00232115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*